AI-powered
podcast player
Listen to all your favourite podcasts with AI-powered features
Regulatory Challenges at the FDA
This chapter explores the implications of deregulation promises made during the Trump administration, especially regarding the FDA's relationship with pharmaceutical companies. It critiques the impact of political influences on drug approval processes, public health, and the ethical considerations stemming from offshoring drug development. The chapter also highlights systemic challenges within the FDA, including workforce competence and the potential consequences for healthcare inequality.